The Global Advanced Empty Capsules Industry is poised for substantial expansion, with revenues expected to reach US$ 905.6 million in 2023 and a projected Compound Annual Growth Rate (CAGR) of 7.4%. By 2033, the market is anticipated to exceed US$ 1,856.1 million. This impressive growth is attributed to several key market-specific factors driving demand and innovation.
Aging Populations and Chronic Diseases The global demographic landscape is undergoing a significant shift, with an ever-increasing aging population and a surge in the prevalence of chronic diseases. These demographic trends have become crucial drivers for the pharmaceutical sector, demanding efficient drug delivery solutions. Advanced empty capsules have emerged as a vital component in this equation, facilitating precise and efficient drug delivery to cater to the specific needs of this growing patient demographic.
Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-13243
For instance, On March 5, 2021, CapsCanada, a Lyfe Group, announced the launch of a new liquid-filled hard capsule manufacturing service. Similarly, Roxlor developed proprietary capsule technologies to produce hard capsules with marine gelatin and from Pullulan, a natural polysaccharide. There is an increasing vegetarian influence on the product portfolio, which is being seen as an alternative to gelatin capsules, providing customized capsules to CROs to conduct pre-clinical and clinical trials, which can save costs incurred on research and development activities.
The worldwide per capita healthcare spending has doubled due to increasing awareness in terms of treatment options. Rapid economic and population growth in addition to increasing disposable incomes are prime factors responsible for the growth of the healthcare industry.
Rising healthcare spending is expected to positively influence the market. This is indicative of the fact that consumers are more willing to pay for advanced and more convenient treatment methods.
Key Takeaways from Advanced Empty Capsule Services Market Study
- Oral capsules accounted for 89.8% of the market in 2021 owing to ease of administration and dosage compliance.
- Demand for vegetarian-based advanced empty capsules will rise at over 9% CAGR, driven by growth in the number of vegan and vegetarian consumers.
- Size “0” capsules will account for more than 20% of the market. Their sales will be driven by ease of consumption and optimal dosage potency.
- Germany holds the lead in Europe with a valuation of US$ 169 Mn 2021 owing to the presence of key production facilities.
- India holds dominance in South Asia and will account for over 60% of the regional sales by 2031.
“Higher adoption of oral capsules, favorable government initiatives, and frequent technological advancements will offer lucrative growth opportunities for empty capsule manufacturers in the long term,” says a Future Market Insights analyst
Discovering the assumptions behind the study. Ask An Analyst
https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-13243
Who is Winning?
Leading manufacturers in the market are strengthening their market position through collaborations. Governments in developed and developing countries are actively taking initiatives to encourage various research activities that will aid developments in this market. Leading organizations within the market are set to focus on research and development to offer an early and precise diagnosis of the ailment, besides offering effective patient care.
For instance, On Feb 19, 2019, ACG Worldwide was the first company in Asia to launch the Polytype coating line. Also, with the addition of the coating line to the Brazil facility, the company aimed to improve service to South American customers. Both developments strengthened global positioning by adding a coating line to the existing manufacturing facilities.
In October 2020, Lonza expanded its capsule manufacturing capacity. The new expansion involved eight global Lonza sites. The investment aimed to address the increasing global demand for capsules. This investment is estimated to expand the capsule manufacturing capacity by 30 billion capsules annually.
Want More Insights?
Future Market Insights brings the comprehensive research report on forecast revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The Global Advanced Empty Capsules Industry is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights into the advanced empty capsule market and segments it on basis of the main indication in detail. It covers every aspect of the market such as product type, molecule type, application, and service provider across seven key regions.
Get Your Customized Impactful Report Now!
https://www.futuremarketinsights.com/customization-available/rep-gb-13243
Global Advanced Empty Capsules Industry by CategoryBy Product Type:
- Oral Capsules
- Dry formulation
- Immediate-release capsules
- Gelatin
- HPMC
- Starch
- Pullulan
- Delayed-release capsules
- Time delayed release capsules
- Gelatin
- HPMC
- Acid-resistant capsules
- Gelatin
- HPMC
- HPMCP
- Enteric capsules
- Gelatin
- HPMC
- HPMC-AS
- Time delayed release capsules
- Immediate-release capsules
- Liquid formulation
- Gelatin
- HPMC
- Starch
- Pullulan
- Dry formulation
- Inhalation Capsules
- Gelatin
- HPMC
- Starch
- Pullulan
By Raw Material:
- Animal Source
- Contract Type-A (Pork Skin
- Type-B Gelatin (Animal Bones & Calf Skin)
- Fish Bone Gelatin
- Vegetarian-based
- Hydroxy Propyl Methyl Cellulose (HPMC)
- Starch
- Pullulan
Author
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube